Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 385

1.

Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.

Donohue MC, Sperling RA, Petersen R, Sun CK, Weiner MW, Aisen PS; Alzheimer’s Disease Neuroimaging Initiative.

JAMA. 2017 Jun 13;317(22):2305-2316. doi: 10.1001/jama.2017.6669.

PMID:
28609533
2.

Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images.

Guo S, Lai C, Wu C, Cen G; Alzheimer's Disease Neuroimaging Initiative.

Front Aging Neurosci. 2017 May 18;9:146. doi: 10.3389/fnagi.2017.00146. eCollection 2017.

3.

Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.

Calis KA, Archdeacon P, Bain R, DeMets D, Donohue M, Elzarrad MK, Forrest A, McEachern J, Pencina MJ, Perlmutter J, Lewis RJ.

Clin Trials. 2017 May 1:1740774517707743. doi: 10.1177/1740774517707743. [Epub ahead of print]

PMID:
28503947
4.

Oligomeric Structure of Anabaena Sensory Rhodopsin in a Lipid Bilayer Environment by Combining Solid-State NMR and Long-range DEER Constraints.

Milikisiyants S, Wang S, Munro RA, Donohue M, Ward ME, Bolton D, Brown LS, Smirnova TI, Ladizhansky V, Smirnov AI.

J Mol Biol. 2017 Jun 16;429(12):1903-1920. doi: 10.1016/j.jmb.2017.05.005. Epub 2017 May 10.

PMID:
28501588
5.

Positively Biased Processing of Mother's Emotions Predicts Children's Social and Emotional Functioning.

Donohue MR, Goodman SH, Tully EC.

Early Child Res Q. 2017 1st Quarter;38:1-9. doi: 10.1016/j.ecresq.2016.08.006. Epub 2016 Oct 6.

PMID:
28348456
6.

Adding Recognition Discriminability Index to the Delayed Recall Is Useful to Predict Conversion from Mild Cognitive Impairment to Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.

Russo MJ, Campos J, Vázquez S, Sevlever G, Allegri RF; Alzheimer's Disease Neuroimaging Initiative.

Front Aging Neurosci. 2017 Mar 10;9:46. doi: 10.3389/fnagi.2017.00046. eCollection 2017.

7.

Construction and Analysis of Weighted Brain Networks from SICE for the Study of Alzheimer's Disease.

Munilla J, Ortiz A, Górriz JM, Ramírez J; Alzheimer's Disease Neuroimaging Initiative.

Front Neuroinform. 2017 Mar 10;11:19. doi: 10.3389/fninf.2017.00019. eCollection 2017.

8.
9.

Robust Identification of Alzheimer's Disease subtypes based on cortical atrophy patterns.

Park JY, Na HK, Kim S, Kim H, Kim HJ, Seo SW, Na DL, Han CE, Seong JK; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2017 Mar 9;7:43270. doi: 10.1038/srep43270.

10.

Reduction in time to treatment in prehospital telemedicine evaluation and thrombolysis.

Taqui A, Cerejo R, Itrat A, Briggs FB, Reimer AP, Winners S, Organek N, Buletko AB, Sheikhi L, Cho SM, Buttrick M, Donohue MM, Khawaja Z, Wisco D, Frontera JA, Russman AN, Hustey FM, Kralovic DM, Rasmussen P, Uchino K, Hussain MS; Cleveland Pre-Hospital Acute Stroke Treatment (PHAST) Group.

Neurology. 2017 Apr 4;88(14):1305-1312. doi: 10.1212/WNL.0000000000003786. Epub 2017 Mar 8.

PMID:
28275084
11.

Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid-β.

Mormino EC, Papp KV, Rentz DM, Donohue MC, Amariglio R, Quiroz YT, Chhatwal J, Marshall GA, Donovan N, Jackson J, Gatchel JR, Hanseeuw BJ, Schultz AP, Aisen PS, Johnson KA, Sperling RA.

Alzheimers Dement. 2017 Feb 28. pii: S1552-5260(17)30044-4. doi: 10.1016/j.jalz.2017.01.018. [Epub ahead of print]

PMID:
28253478
12.

Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.

Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2017 Feb 7;88(6):569-576. doi: 10.1212/WNL.0000000000003585. Epub 2017 Jan 6.

PMID:
28062720
13.

Nationwide reconnaissance of contaminants of emerging concern in source and treated drinking waters of the United States.

Glassmeyer ST, Furlong ET, Kolpin DW, Batt AL, Benson R, Boone JS, Conerly O, Donohue MJ, King DN, Kostich MS, Mash HE, Pfaller SL, Schenck KM, Simmons JE, Varughese EA, Vesper SJ, Villegas EN, Wilson VS.

Sci Total Environ. 2017 Mar 1;581-582:909-922. doi: 10.1016/j.scitotenv.2016.12.004. Epub 2016 Dec 24.

14.

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology.

Schmitz TW, Nathan Spreng R; Alzheimer's Disease Neuroimaging Initiative.

Nat Commun. 2016 Nov 4;7:13249. doi: 10.1038/ncomms13249.

15.

Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.

Zhang X, Mormino EC, Sun N, Sperling RA, Sabuncu MR, Yeo BT; Alzheimer’s Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6535-E6544. Epub 2016 Oct 4.

16.

Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairment.

Insel PS, Donohue MC, Mackin RS, Aisen PS, Hansson O, Weiner MW, Mattsson N; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2016 Dec;48:172-181. doi: 10.1016/j.neurobiolaging.2016.08.017. Epub 2016 Aug 26.

PMID:
27710807
17.

Increasing Prevalence Rate of Nontuberculous Mycobacteria Infections in Five States, 2008-2013.

Donohue MJ, Wymer L.

Ann Am Thorac Soc. 2016 Dec;13(12):2143-2150.

PMID:
27681202
18.

Infection Rates of Electrical Leads Used for Percutaneous Neurostimulation of the Peripheral Nervous System.

Ilfeld BM, Gabriel RA, Saulino MF, Chae J, Peckham PH, Grant SA, Gilmore CA, Donohue MC, deBock MG, Wongsarnpigoon A, Boggs JW.

Pain Pract. 2016 Sep 27. doi: 10.1111/papr.12523. [Epub ahead of print]

PMID:
27676323
19.

Morphometricity as a measure of the neuroanatomical signature of a trait.

Sabuncu MR, Ge T, Holmes AJ, Smoller JW, Buckner RL, Fischl B; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):E5749-56. doi: 10.1073/pnas.1604378113. Epub 2016 Sep 9.

20.

Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.

Beckelman BC, Day S, Zhou X, Donohue M, Gouras GK, Klann E, Keene CD, Ma T.

J Alzheimers Dis. 2016 Sep 6;54(2):669-78. doi: 10.3233/JAD-160036.

Supplemental Content

Loading ...
Support Center